Top 100 Contractors in PSC AN: Health R&D Services, Aug 2025–Jul 2026

Parent companies by net contract obligations Aug 1, 2025 – Jul 31, 2026 Code page on GovTribe

The latest 12 months. See the newest fiscal year's list: Top Contractors in PSC AN: Health R&D Services, FY2025.

The top 10 won 44% of PSC AN contract dollars from August 2025 through July 2026

Ranking facts

Contract obligations
$3,910,930,382 Net of deobligations, by contracts coded PSC AN or a code under it
Contractors
568 Parent companies with an obligation
Largest contractor
Leidos Holdings, Inc. $895 million, 19.8% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)

Full ranking

Rank Contractor Net obligations Share Trend
1 $895,228,991
Rank history: #1 in FY2021, #1 in FY2022, #2 in FY2023, #3 in FY2024 and #1 in FY2025; unchanged since Aug 2024–Jul 2025.
2 $247,999,997
Rank history: not on the FY2021–FY2022 lists, #1 in FY2023, #1 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
3 $174,576,446
Rank history: #5 in FY2021, #4 in FY2022, #7 in FY2023, #4 in FY2024 and #2 in FY2025; unchanged since Aug 2024–Jul 2025.
4 $119,160,688
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
5 $117,505,224
Rank history: not on the FY2021–FY2023 lists, #27 in FY2024 and #3 in FY2025; up 18 since Aug 2024–Jul 2025.
6 $113,641,157
Rank history: not on the FY2021 list, #10 in FY2022, #26 in FY2023, #13 in FY2024 and not on the FY2025 list; up 2 since Aug 2024–Jul 2025.
7 $88,055,459
Rank history: #49 in FY2021, #30 in FY2022, #32 in FY2023, #10 in FY2024 and #8 in FY2025; up 2 since Aug 2024–Jul 2025.
8 $87,380,865
Rank history: #8 in FY2021, #5 in FY2022, #19 in FY2023, #12 in FY2024 and #7 in FY2025; up 2 since Aug 2024–Jul 2025.
9 $85,953,257
Rank history: #6 in FY2021, #7 in FY2022, #16 in FY2023, #8 in FY2024 and #6 in FY2025; down 3 since Aug 2024–Jul 2025.
10 $74,027,460
Rank history: not on the FY2021–FY2023 lists, #30 in FY2024 and #11 in FY2025; up 2 since Aug 2024–Jul 2025.
11 $63,705,626
Rank history: #9 in FY2021, #14 in FY2022, #3 in FY2023, #15 in FY2024 and #10 in FY2025; unchanged since Aug 2024–Jul 2025.
12 $59,988,840
Rank history: not on the FY2021–FY2023 lists, #9 in FY2024 and #5 in FY2025; down 8 since Aug 2024–Jul 2025.
13
Merck & Co. Inc. 2 awardees, including Cidara Therapeutics Inc.
$57,816,482
Rank history: not on the FY2021–FY2024 lists and #12 in FY2025; new, not ranked in Aug 2024–Jul 2025.
14 $52,936,200
Rank history: #61 in FY2021, not on the FY2022–FY2023 lists, #100 in FY2024 and #43 in FY2025; up 88 since Aug 2024–Jul 2025.
15 $51,249,013
Rank history: #20 in FY2021, #26 in FY2022, #33 in FY2023, #20 in FY2024 and #17 in FY2025; up 13 since Aug 2024–Jul 2025.
16 $49,804,498
Rank history: #26 in FY2021, #60 in FY2022, #54 in FY2023, #33 in FY2024 and #14 in FY2025; up 6 since Aug 2024–Jul 2025.
17
Ossium Health Inc.
$39,993,959
Rank history: not on the FY2021–FY2023 lists, #39 in FY2024 and not on the FY2025 list; up 20 since Aug 2024–Jul 2025.
18 $38,297,749
Rank history: #37 in FY2021, #72 in FY2022, #25 in FY2023, #62 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
19 $33,513,537
Rank history: not on the FY2021–FY2024 lists and #18 in FY2025; new, not ranked in Aug 2024–Jul 2025.
20 $30,550,154
Rank history: #14 in FY2021, #13 in FY2022, #21 in FY2023, #17 in FY2024 and #19 in FY2025; down 4 since Aug 2024–Jul 2025.
21 $30,000,000
Rank history: not on the FY2021–FY2023 lists, #6 in FY2024 and #4 in FY2025; down 16 since Aug 2024–Jul 2025.
22
PPD Development LP
$29,122,693
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
23 $28,855,729
Rank history: not on the FY2021–FY2023 lists, #42 in FY2024 and #49 in FY2025; up 11 since Aug 2024–Jul 2025.
24 $27,246,495
Rank history: not on the FY2021–FY2022 lists, #88 in FY2023, #24 in FY2024 and #34 in FY2025; up 6 since Aug 2024–Jul 2025.
25 $25,895,865
Rank history: not on the FY2021–FY2023 lists, #35 in FY2024 and #22 in FY2025; up 85 since Aug 2024–Jul 2025.
26 $25,632,685
Rank history: #76 in FY2021, #24 in FY2022, #20 in FY2023, #29 in FY2024 and #15 in FY2025; down 9 since Aug 2024–Jul 2025.
27 $25,543,758
Rank history: not on the FY2021–FY2024 lists and #27 in FY2025; new, not ranked in Aug 2024–Jul 2025.
28 $25,164,757
Rank history: not on the FY2021–FY2024 lists and #28 in FY2025; down 1 since Aug 2024–Jul 2025.
29 $25,017,292
Rank history: #42 in FY2021, #82 in FY2022, #81 in FY2023, #49 in FY2024 and #68 in FY2025; up 28 since Aug 2024–Jul 2025.
30 $24,263,665
Rank history: #73 in FY2021, #70 in FY2022, not on the FY2023–FY2024 lists and #87 in FY2025; new, not ranked in Aug 2024–Jul 2025.
31 $23,714,760
Rank history: not on the FY2021–FY2024 lists and #52 in FY2025; up 36 since Aug 2024–Jul 2025.
32 $23,692,418
Rank history: not on the FY2021–FY2024 lists and #81 in FY2025; up 93 since Aug 2024–Jul 2025.
33 $23,322,111
Rank history: #21 in FY2021, #21 in FY2022, #31 in FY2023, #22 in FY2024 and #21 in FY2025; down 18 since Aug 2024–Jul 2025.
34 $21,416,911
Rank history: #15 in FY2021, #42 in FY2022, #57 in FY2023, #25 in FY2024 and #29 in FY2025; up 5 since Aug 2024–Jul 2025.
35 $21,335,789
Rank history: not on the FY2021–FY2022 lists, #61 in FY2023, not on the FY2024 list and #33 in FY2025; up 103 since Aug 2024–Jul 2025.
36 $21,076,616
Rank history: not on the FY2021–FY2024 lists and #36 in FY2025; new, not ranked in Aug 2024–Jul 2025.
37 $21,014,610
Rank history: not on the FY2021 list, #29 in FY2022, not on the FY2023–FY2024 lists and #45 in FY2025; up 6 since Aug 2024–Jul 2025.
38 $20,948,763
Rank history: not on the FY2021–FY2024 lists and #72 in FY2025; new, not ranked in Aug 2024–Jul 2025.
39
Virginia Commonwealth University Health System Authority Through Virginia Polytechnic Institute & State University
$20,308,180
Rank history: not on the FY2021–FY2024 lists and #37 in FY2025; new, not ranked in Aug 2024–Jul 2025.
40 $20,000,000
Rank history: not on the FY2021–FY2024 lists and #40 in FY2025; new, not ranked in Aug 2024–Jul 2025.
41 $19,601,012
Rank history: not on the FY2021–FY2024 lists and #41 in FY2025; new, not ranked in Aug 2024–Jul 2025.
42 $19,267,435
Rank history: not on the FY2021 list, #65 in FY2022, not on the FY2023–FY2024 lists and #46 in FY2025; up 33 since Aug 2024–Jul 2025.
43 $18,959,429
Rank history: #78 in FY2021, #93 in FY2022, not on the FY2023–FY2024 lists and #57 in FY2025; new, not ranked in Aug 2024–Jul 2025.
44 $18,932,966
Rank history: #100 in FY2021, #77 in FY2022, #73 in FY2023, #23 in FY2024 and #25 in FY2025; up 5 since Aug 2024–Jul 2025.
45 $18,821,402
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
46 $18,561,868
Rank history: not on the FY2021–FY2024 lists and #62 in FY2025; new, not ranked in Aug 2024–Jul 2025.
47 $18,177,254
Rank history: not on the FY2021–FY2024 lists and #47 in FY2025; new, not ranked in Aug 2024–Jul 2025.
48 $17,387,081
Rank history: #23 in FY2021, #27 in FY2022, #39 in FY2023, #31 in FY2024 and #51 in FY2025; down 24 since Aug 2024–Jul 2025.
49 $16,952,932
Rank history: not on the FY2021–FY2024 lists and #54 in FY2025; new, not ranked in Aug 2024–Jul 2025.
50 $16,625,212
Rank history: not on the FY2021–FY2024 lists and #42 in FY2025; up 54 since Aug 2024–Jul 2025.
51 $15,487,955
Rank history: not on the FY2021–FY2024 lists and #61 in FY2025; up 31 since Aug 2024–Jul 2025.
52 $15,099,063
Rank history: #32 in FY2021, #67 in FY2022, #55 in FY2023, #45 in FY2024 and #56 in FY2025; down 23 since Aug 2024–Jul 2025.
53 $15,002,035
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
54 $14,915,394
Rank history: #39 in FY2021, #66 in FY2022, #34 in FY2023, #51 in FY2024 and #30 in FY2025; up 2 since Aug 2024–Jul 2025.
55 $14,668,854
Rank history: #54 in FY2021, #83 in FY2022, #72 in FY2023, not on the FY2024 list and #48 in FY2025; new, not ranked in Aug 2024–Jul 2025.
56 $14,571,972
Rank history: not on the FY2021–FY2024 lists and #50 in FY2025; new, not ranked in Aug 2024–Jul 2025.
57 $14,231,864
Rank history: not on the FY2021 list, #75 in FY2022, not on the FY2023 list, #50 in FY2024 and not on the FY2025 list; up 32 since Aug 2024–Jul 2025.
58 $14,131,077
Rank history: not on the FY2021–FY2024 lists and #63 in FY2025; new, not ranked in Aug 2024–Jul 2025.
59 $14,059,017
Rank history: not on the FY2021–FY2024 lists and #90 in FY2025; new, not ranked in Aug 2024–Jul 2025.
60 $13,939,345
Rank history: not on the FY2021–FY2024 lists and #84 in FY2025; up 74 since Aug 2024–Jul 2025.
61
Hoffmann-La Roche Inc.
$13,750,000
Rank history: not on the FY2021–FY2024 lists and #16 in FY2025; new, not ranked in Aug 2024–Jul 2025.
62 $13,715,173
Rank history: #36 in FY2021, #59 in FY2022, #71 in FY2023, #61 in FY2024 and #67 in FY2025; up 30 since Aug 2024–Jul 2025.
63 $13,686,764
Rank history: not on the FY2021–FY2022 lists, #79 in FY2023, #59 in FY2024 and #65 in FY2025; down 9 since Aug 2024–Jul 2025.
64 $13,437,694
Rank history: not on the FY2021–FY2024 lists and #66 in FY2025; new, not ranked in Aug 2024–Jul 2025.
65 $13,075,601
Rank history: #18 in FY2021, #37 in FY2022, #28 in FY2023, #26 in FY2024 and #31 in FY2025; down 45 since Aug 2024–Jul 2025.
66 $11,958,411
Rank history: not on the FY2021–FY2024 lists and #39 in FY2025; down 31 since Aug 2024–Jul 2025.
67 $11,891,248
Rank history: not on the FY2021–FY2024 lists and #73 in FY2025; new, not ranked in Aug 2024–Jul 2025.
68 $11,857,338
Rank history: not on the FY2021–FY2023 lists, #47 in FY2024 and #20 in FY2025; down 21 since Aug 2024–Jul 2025.
69 $11,384,330
Rank history: #43 in FY2021, #39 in FY2022, #62 in FY2023, #68 in FY2024 and #95 in FY2025; up 2 since Aug 2024–Jul 2025.
70 $11,291,005
Rank history: not on the FY2021–FY2024 lists and #75 in FY2025; new, not ranked in Aug 2024–Jul 2025.
71 $11,049,460
Rank history: not on the FY2021–FY2024 lists and #79 in FY2025; new, not ranked in Aug 2024–Jul 2025.
72 $10,883,374
Rank history: not on the FY2021–FY2024 lists and #74 in FY2025; up 21 since Aug 2024–Jul 2025.
73 $10,837,975
Rank history: not on the FY2021 list, #91 in FY2022, #90 in FY2023, #96 in FY2024 and #77 in FY2025; up 44 since Aug 2024–Jul 2025.
74 $10,762,189
Rank history: not on the FY2021–FY2023 lists, #87 in FY2024 and #26 in FY2025; down 48 since Aug 2024–Jul 2025.
75 $10,541,742
Rank history: #38 in FY2021, #51 in FY2022, #60 in FY2023, #40 in FY2024 and #35 in FY2025; down 37 since Aug 2024–Jul 2025.
76 $10,538,088
Rank history: not on the FY2021–FY2023 lists, #32 in FY2024 and #91 in FY2025; new, not ranked in Aug 2024–Jul 2025.
77 $10,483,494
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
78 $10,397,057
Rank history: not on the FY2021–FY2024 lists and #80 in FY2025; up 42 since Aug 2024–Jul 2025.
79 $10,364,155
Rank history: not on the FY2021–FY2023 lists, #37 in FY2024 and #58 in FY2025; down 28 since Aug 2024–Jul 2025.
80 $10,259,311
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
81 $10,229,292
Rank history: #94 in FY2021, #81 in FY2022, #87 in FY2023, #83 in FY2024 and #93 in FY2025; up 3 since Aug 2024–Jul 2025.
82 $10,057,156
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
83 $9,976,549
Rank history: not on the FY2021–FY2025 lists; up 49 since Aug 2024–Jul 2025.
84 $9,899,714
Rank history: not on the FY2021 list, #80 in FY2022, #69 in FY2023, #76 in FY2024 and #88 in FY2025; up 3 since Aug 2024–Jul 2025.
85 $9,628,264
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
86
Charles River Laboratories International Inc. Through Charles River Laboratories, Inc.
$9,428,450
Rank history: not on the FY2021–FY2023 lists, #93 in FY2024 and #71 in FY2025; down 26 since Aug 2024–Jul 2025.
87 $9,364,971
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
88 $9,307,613
Rank history: not on the FY2021–FY2023 lists, #89 in FY2024 and #92 in FY2025; unchanged since Aug 2024–Jul 2025.
89 $9,263,158
Rank history: #59 in FY2021, #97 in FY2022, #77 in FY2023, #71 in FY2024 and #64 in FY2025; down 36 since Aug 2024–Jul 2025.
90 $8,974,230
Rank history: not on the FY2021–FY2022 lists, #50 in FY2023, #67 in FY2024 and #23 in FY2025; down 72 since Aug 2024–Jul 2025.
91
Biofire Defense LLC 2 awardees, including Advanced Bioscience Laboratories, Inc.
$8,904,509
Rank history: not on the FY2021–FY2023 lists, #70 in FY2024 and not on the FY2025 list; up 51 since Aug 2024–Jul 2025.
92 $8,700,000
Rank history: not on the FY2021–FY2023 lists, #73 in FY2024 and #89 in FY2025; down 27 since Aug 2024–Jul 2025.
93 $8,628,007
Rank history: not on the FY2021–FY2025 lists; up 150 since Aug 2024–Jul 2025.
94 $8,450,715
Rank history: not on the FY2021–FY2024 lists and #99 in FY2025; new, not ranked in Aug 2024–Jul 2025.
95 $8,375,271
Rank history: not on the FY2021–FY2024 lists and #100 in FY2025; new, not ranked in Aug 2024–Jul 2025.
96 $7,998,548
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
97 $7,751,793
Rank history: #95 in FY2021, #90 in FY2022, #78 in FY2023, #57 in FY2024 and #83 in FY2025; down 39 since Aug 2024–Jul 2025.
98 $7,677,521
Rank history: not on the FY2021–FY2022 lists, #66 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
99 $7,614,197
Rank history: not on the FY2021–FY2025 lists; up 8 since Aug 2024–Jul 2025.
100 $7,529,420
Rank history: not on the FY2021–FY2022 lists, #86 in FY2023 and not on the FY2024–FY2025 lists; up 6 since Aug 2024–Jul 2025.
Show 75 more

100 of 568 contractors listed here. See the rest on GovTribe.

Rankings for the codes under PSC AN

Code Net obligations Largest contractor
AN12 Health R&D Services; Health Care Services; Applied Research $1,577,403,803 Leidos Holdings, Inc.
AN42 Health R&D Services; Health Care – Other; Applied Research $899,099,182 Analytic Services Inc.
AN13 Health R&D Services; Health Care Services; Experimental Development $518,749,606 Shionogi & Company Limited
AN11 Health R&D Services; Health Care Services; Basic Research $365,906,585 The Mitre Corporation
AN14 Health R&D Services; Health Care Services; R&D Administrative Expenses $131,373,677 Cidara Therapeutics Inc.
AN41 Health R&D Services; Health Care – Other; Basic Research $67,704,459 Trustees of Boston University

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $4.53 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
  • Rank changes compare with Aug 2024–Jul 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC AN contractors in Aug 2025–Jul 2026?

1. Leidos Holdings, Inc. ($895M), 2. Analytic Services Inc. ($248M), 3. Medical Technology Enterprise Consortium ($175M), 4. Shionogi & Company Limited ($119M), 5. Start2 Group, Inc. ($118M), 6. Phlow Corp. ($114M), 7. Mathematica Inc. ($88.1M), 8. Westat, Inc. ($87.4M), 9. The Mitre Corporation ($86M), 10. Basilea Pharmaceutica AG ($74M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work